Table 4.

Percentage Changes in Volumetric Functional Metrics and Anatomic Metrics in Responders and Nonresponders according to Respective Criteria

Note.—Unless otherwise indicated, data are means ± standard deviations. For RECIST, EASL, and mRECIST, responders were those with complete response and partial response, and nonresponders were those with stable disease and progressive disease. There was significant decrease in tumor size according to RECIST and enhancement according to EASL and mRECIST in responders compared with nonresponders according to respective criteria. However, response according to RECIST, EASL, and mRECIST did not predict patient survival.

^*P value is obtained from independent-samples t test.